• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by Southwest Airlines Company

    10/24/24 8:30:19 AM ET
    $LUV
    Air Freight/Delivery Services
    Consumer Discretionary
    Get the next $LUV alert in real time by email
    SC 13D/A 1 p24-3063sc13da.htm SOUTHWEST AIRLINES CO
    SECURITIES AND EXCHANGE COMMISSION  
    Washington, D.C. 20549  
       

    SCHEDULE 13D

    (Amendment No. 5)*

     
    Under the Securities Exchange Act of 1934
     

    Southwest Airlines Co.

    (Name of Issuer)
     

    Common Stock, par value $1.00 per share

    (Title of Class of Securities)
     

    844741108

    (CUSIP Number)
     

    Elliott Investment Management L.P.

    360 S. Rosemary Ave, 18th Floor

    West Palm Beach, FL 33401

     

    with a copy to:

    Eleazer Klein, Esq.
    Adriana Schwartz, Esq.

    Schulte Roth & Zabel LLP

    919 Third Avenue

    New York, New York 10022

    (212) 756-2000

    (Name, Address and Telephone Number of Person
    Authorized to Receive Notices and Communications)
     

    October 23, 2024

    (Date of Event Which Requires Filing of This Statement)
     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. ¨

     

    (Page 1 of 6 Pages)

    ______________________________

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 844741108Schedule 13D/APage 2 of 6 Pages

     

    1

    NAME OF REPORTING PERSON

    Elliott Investment Management L.P.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☒

    (b) ¨

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS

    OO

    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    7

    SOLE VOTING POWER

    61,116,500

    8

    SHARED VOTING POWER

    -0-

    9

    SOLE DISPOSITIVE POWER

    61,116,500

    10

    SHARED DISPOSITIVE POWER

    -0-

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

    61,116,500

    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    10.2%

    14

    TYPE OF REPORTING PERSON

    PN, IA

             

     

     

    CUSIP No. 844741108Schedule 13D/APage 3 of 6 Pages

      

    The following constitutes Amendment No. 5 to the Schedule 13D (“Amendment No. 5”).  This Amendment No. 5 amends the Schedule 13D as specifically set forth herein.
     
    Item 2. IDENTITY AND BACKGROUND
     
    Item 2 of the Schedule 13D is hereby amended and restated in its entirety to read as follows:
     
    (a)-(c) This statement is being filed by Elliott Investment Management L.P., a Delaware limited partnership (“EIM” or the “Reporting Person”), the investment manager of Elliott Associates, L.P., a Delaware limited partnership (“Elliott”) and Elliott International, L.P., a Cayman Islands limited partnership (“Elliott International”, and together with Elliott, the “Elliott Funds”), with respect to the shares of Common Stock held by the Elliott Funds and/or their respective subsidiaries.  Elliott Investment Management GP LLC, a Delaware limited liability company (“EIM GP”), is the sole general partner of EIM.  Paul E. Singer (“Singer”) is the sole managing member of EIM GP.  
     
    EIM
     
    The business address of EIM is 360 S. Rosemary Ave, 18th Floor, West Palm Beach, FL 33401.
     
    The principal business of EIM is to act as investment manager for the Elliott Funds.
     
    The name, business address, and present principal occupation or employment of the general partner of EIM is as follows:
     
    NAME ADDRESS OCCUPATION
         
    Elliott Investment Management GP LLC 360 S. Rosemary Ave, 18th Floor, West Palm Beach, FL 33401 General partner of EIM
     
    EIM GP
     
    The business address of EIM GP is 360 S. Rosemary Ave, 18th Floor, West Palm Beach, FL 33401.
     
    The principal business of EIM GP is serving as a general partner of EIM.
     
    The name, business address, and present principal occupation or employment of the managing member of EIM GP is as follows:
     
    NAME ADDRESS OCCUPATION
         
    Paul E. Singer 360 S. Rosemary Ave, 18th Floor, West Palm Beach, FL 33401 Sole managing member of EIM GP
     
    SINGER
     
    Singer’s business address is 360 S. Rosemary Ave, 18th Floor, West Palm Beach, FL 33401.
     
    Singer’s principal business is to serve as the sole managing member of EIM GP.
           

     

    CUSIP No. 844741108Schedule 13D/APage 4 of 6 Pages

      

    (d) and (e) During the last five years, none of the persons or entities listed above has been (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
     
    (f) See Items 2(a)-(c) above.  Singer is a citizen of the United States of America.

     

    Item 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
       
    Item 3 of the Schedule 13D is hereby amended and restated in its entirety to read as follows:
       
    The aggregate cost of the shares of Common Stock directly held by the Elliott Funds is approximately $1,603,847,662.  
       
    The Reporting Person may effect purchases of the shares of Common Stock through margin accounts maintained for the Elliott Funds with prime brokers, which extend margin credit as and when required to open or carry positions in their margin accounts, subject to applicable federal margin regulations, stock exchange rules and such firms’ credit policies.  Positions in the shares of Common Stock may be held in margin accounts and may be pledged as collateral security for the repayment of debit balances in such accounts.  Since other securities may be held in such margin accounts, it may not be possible to determine the amounts, if any, of margin used to purchase the shares of Common Stock.

     

    Item 4. PURPOSE OF TRANSACTION
       
    Item 4 of the Schedule 13D is hereby amended and supplemented to add the following:
       
    On October 23, 2024, EIM and the Elliott Funds entered into a cooperation agreement with the Issuer (the “Cooperation Agreement”). Concurrent with the execution of the Cooperation Agreement, the Elliott Funds and EIM irrevocably withdrew the Special Meeting Request and all related materials and notices submitted to the Issuer in connection therewith or related thereto. The full text of the Cooperation Agreement is included as Exhibit 99.9 and is incorporated by reference herein.  In addition, EIM terminated each of the Candidate Agreements with each of the Nominee Reporting Persons previously disclosed in Item 4 of the Schedule 13D.  Accordingly, each of the Nominee Reporting Persons is no longer a Reporting Person on this Schedule 13D, and may no longer be deemed to be part of a “group” with EIM.

     

    Item 5. INTEREST IN SECURITIES OF THE ISSUER
       
    Items 5(a)-(d) of the Schedule 13D are hereby amended and restated to read as follows:
       

    (a) See rows (11) and (13) of the cover page to this Schedule 13D for the aggregate number of shares of Common Stock and percentage of shares of Common Stock beneficially owned by each Reporting Person. The aggregate percentage of shares of Common Stock reported beneficially owned by each Reporting Person is based upon 599,157,019 shares of Common Stock outstanding as of July 25, 2024, as disclosed in the Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024, filed by the Issuer with the Securities and Exchange Commission on July 29, 2024.

     

    (b) See rows (7) through (10) of the cover page to this Schedule 13D for the shares of Common Stock as to which the Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

     

    CUSIP No. 844741108Schedule 13D/APage 5 of 6 Pages

      

    (c) No transactions in the shares of Common Stock have been effected by the Reporting Person since the filing of Amendment No. 4.
     
    (d) No persons other than the Elliott Funds and/or their respective subsidiaries and EIM have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by EIM.

     

    Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER
       
    Item 6 of the Schedule 13D is hereby amended and supplemented to add the following:
       
    Item 4 of this Amendment No. 5 is incorporated herein by reference.

     

    Item 7. EXHIBITS
       
    Item 7 of the Schedule 13D is hereby amended and supplemented to add the following:
       
    Exhibit 99.9: Cooperation Agreement, dated October 23, 2024 (incorporated by reference to Exhibit 10.1 of the Issuer’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 24, 2024).

     

     

     

    CUSIP No. 844741108Schedule 13D/APage 6 of 6 Pages

     

    SIGNATURES

    After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

    DATE: October 24, 2024

     

    Elliott Investment Management L.P.  
       
    /s/ Elliot Greenberg  
    Name: Elliot Greenberg  
    Title: Vice President  

     

    Get the next $LUV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LUV

    DatePrice TargetRatingAnalyst
    5/29/2025$40.00Hold → Buy
    Deutsche Bank
    5/27/2025$33.00Underperform → Hold
    Jefferies
    4/1/2025$28.00Hold → Underperform
    Jefferies
    3/20/2025$29.00 → $36.00Sell → Neutral
    UBS
    3/20/2025Sell → Hold
    Melius
    3/3/2025$25.00Neutral → Underweight
    Analyst
    2/11/2025$35.00Hold → Buy
    Argus
    1/17/2025$31.00Neutral → Underperform
    BofA Securities
    More analyst ratings